Delivery Order SPE2DB24D1007-SPE2DB25FBZKK
Award Date
11/21/24
Potential Completion Date
11/22/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,501.07, is for the delivery of 180 tablets of 800 mg delayed-release mesalamine, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract has a period of performance through June 12, 2024 and is a Firm Fixed Price Delivery Order. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,278.66, is for the delivery of 180 tablets of Mesalamine 800 mg delayed-release tablets, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,130.82 delivery order contract is for the supply of 120 tablets of Mesalamine, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract has a firm fixed price and runs through May 5, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,284.56 fixed-price delivery order is for the supply of 180 capsules of 400 mg Mesalamine, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract has an ultimate completion date of March 19, 2025 and is not designated with any set-aside requirements, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of 1.2 gram Mesalamine, a medication used to treat conditions such as ulcerative colitis. The award has a ceiling value of $1,184.05 and is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of January 28, 2025. The contract is not designated with a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,419.32 firm fixed-price delivery order is for the supply of 180 tablets of 800 mg Mesalamine, a medication used to treat certain gastrointestinal conditions. The award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,322.21 fixed-price delivery order is for the supply of 120 tablets of Mesalamine DR 1.2 GM, a medication used to treat certain gastrointestinal conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
This federal contract award, with a unique identifier of SPE2DB22D3016|SPE2DB25FAMZ8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,209.80, is for the delivery of Mesalamine delayed-release tablets, a medication used to treat ulcerative colitis and other gastrointestinal conditions. This is a firm-fixed-price delivery order contract with a completion date of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,061.39 contract is for the delivery of 120-count tablets of the drug mesalamine 1.2 grams, a medication used to treat ulcerative colitis. The contract has a firm fixed price and an ultimate completion date of October 2, 2023. This award is not designated as a set-aside contract. AmerisourceBergen holds...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $17,541.47, is for the delivery of Mesalamine 800 mg delayed-release tablets. This award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a...